Approval · Notice of Compliance 7341 · 2005
ADVICOR: Notice of Compliance 7341
Issued August 30, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7341
- Date
- August 30, 2005
- Company
- Oryx Pharmaceuticals Inc., A Subsidiary Of Filiale D'arrow Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
Medicinal ingredients
- LOVASTATIN 20 MG per TAB
- NICOTINIC ACID 500 MG per TAB
- NICOTINIC ACID 1,000 MG per TAB